NRIX
Nurix Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -7.1% ·
flujo de acciones -2.0% ·
nuevas posiciones netas -7.7%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | +2 | 57.55M | $1.40B | +9 | −7 |
| Q1 2026 | 81 | +9 | 58.06M | $899.96M | +14 | −5 |
| Q4 2025 | 72 | -4 | 55.79M | $1.06B | — | −4 |
| Q3 2025 | 18 | +1 | 36.35M | $335.90M | +1 | — |
| Q2 2025 | 14 | -2 | 38.82M | $442.11M | — | −2 |
| Q1 2025 | 13 | 0 | 15.31M | $181.88M | +1 | −1 |
| Q4 2024 | 13 | -1 | 15.53M | $292.61M | +1 | −2 |
| Q3 2024 | 13 | -1 | 13.04M | $292.98M | +1 | −2 |
| Q2 2024 | 14 | — | 12.64M | $263.85M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.59M | +3.0% | $67.57M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 3.01M | -2.0% | $56.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.01M | -2.0% | $56.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (pasivo) | 2.80M | — | $52.81M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasivo) | 1.59M | +9.5% | $29.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 1.59M | +9.5% | $29.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | ARK Investment Management ✦ | 1.53M | -30.9% | $28.83M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 872.96K | Nuevo | $16.45M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 851.52K | -44.4% | $16.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 851.52K | -44.4% | $16.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 424.14K | +91.3% | $7.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Norges Bank ✦ (pasivo) | 318.80K | 0.0% | $6.01M | 0.0% | Held | 3 | SEC ↗ |
| 18 | PRIMECAP Management ✦ | 232.00K | -20.0% | $4.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 135.08K | +166.4% | $2.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 112.84K | +54.9% | $2.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 70.86K | +51.0% | $1.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 70.86K | +51.0% | $1.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 70.86K | +51.0% | $1.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $16.45M | 0.0% |
Posición cerrada
| Renaissance Technologies | $5.54M | era 0.0% |
| Duquesne Family Office | $993,000 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 194 tenedores, 116.98M acciones, $1.75B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.